BGM0504
Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects
BrightGene Bio-Medical Technology Co · Phase 1 · Completed · Enrollment 80
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.